The Translocator Protein (18 kDa): Central Nervous System Disease and Drug Design

被引:90
|
作者
Scarf, Alana M. [1 ,2 ]
Ittner, Lars M. [1 ,3 ]
Kassiou, Michael [1 ,4 ,5 ]
机构
[1] Brain & Mind Res Inst, Camperdown, NSW 2050, Australia
[2] Univ Sydney, Dept Pharmacol, Sydney, NSW 2006, Australia
[3] Univ Sydney, Sch Med Sci, Sydney, NSW 2006, Australia
[4] Univ Sydney, Discipline Med Radiat Sci, Sydney, NSW 2006, Australia
[5] Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia
关键词
PERIPHERAL BENZODIAZEPINE-RECEPTOR; DIAZEPAM-BINDING INHIBITOR; TUMOR-NECROSIS-FACTOR; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; POSITRON-EMISSION-TOMOGRAPHY; ADENINE-NUCLEOTIDE CARRIER; DEPENDENT ANION CHANNEL; RAT SCIATIC-NERVE; CELLS IN-VITRO; MICROGLIAL ACTIVATION;
D O I
10.1021/jm8011678
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
[No abstract available]
引用
收藏
页码:581 / 592
页数:12
相关论文
共 50 条
  • [21] Targeting the 18-kDa translocator protein: recent perspectives for neuroprotection
    Da Pozzo, Eleonora
    Giacomelli, Chiara
    Barresi, Elisabetta
    Costa, Barbara
    Taliani, Sabrina
    Passetti, Federico Da Settimo
    Martini, Claudia
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2015, 43 : 559 - 565
  • [22] The translocator protein as a drug target in Alzheimer's disease
    Chua, Sook W.
    Kassiou, Michael
    Ittner, Lars M.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2014, 14 (04) : 439 - 448
  • [23] Mapping of Translocator Protein (18 kDa) in Peripheral Sterile Inflammatory Disease and Cancer through PET Imaging
    Adhikari, Anupriya
    Singh, Priya
    Mahar, Kamalesh S.
    Adhikari, Manish
    Adhikari, Bhawana
    Zhang, Ming-Rong
    Tiwari, Anjani Kumar
    MOLECULAR PHARMACEUTICS, 2021, 18 (04) : 1507 - 1529
  • [24] Bridging Pharmaceutical Chemistry with Drug and Nanoparticle Targeting to Investigate the Role of the 18-kDa Translocator Protein TSPO
    Iacobazzi, Rosa Maria
    Lopalco, Antonio
    Cutrignelli, Annalisa
    Laquintana, Valentino
    Lopedota, Angela
    Franco, Massimo
    Denora, Nunzio
    CHEMMEDCHEM, 2017, 12 (16) : 1261 - 1274
  • [25] Structural Requirements to Obtain Highly Potent and Selective 18 kDa Translocator Protein (TSPO) Ligands
    Taliani, Sabrina
    Pugliesi, Isabella
    Da Settimo, Federico
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2011, 11 (07) : 860 - 886
  • [26] Central Nervous System Expression and PET Imaging of the Translocator Protein in Relapsing-Remitting Experimental Autoimmune Encephalomyelitis
    Mattner, Filomena
    Staykova, Maria
    Berghofer, Paula
    Wong, Heng Jian
    Fordham, Susan
    Callaghan, Paul
    Jackson, Timothy
    Tien Pham
    Gregoire, Marie-Claude
    Zahra, David
    Rahardjo, Gita
    Linares, David
    Katsifis, Andrew
    JOURNAL OF NUCLEAR MEDICINE, 2013, 54 (02) : 291 - 298
  • [27] Translocator Protein 18 kDa Negatively Regulates Inflammation in Microglia
    Bae, Keun-Ryung
    Shim, Hyun-Jung
    Balu, Deebika
    Kim, Sang Ryong
    Yu, Seong-Woon
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2014, 9 (03) : 424 - 437
  • [28] 18 kDa translocator protein - implications in cell's functions
    Kolodziejczyk, Agnieszka
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2015, 69 : 34 - 50
  • [29] Therapeutic actions of translocator protein (18 kDa) ligands in experimental models of psychiatric disorders and neurodegenerative diseases
    Arbo, B. D.
    Benetti, F.
    Garcia-Segura, L. M.
    Ribeiro, M. F.
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2015, 154 : 68 - 74
  • [30] Visualization of translocator protein (18 kDa) (TSPO) in the retina of diabetic retinopathy rats using fluorine-18-DPA-714
    Zhou, Yujing
    Ou, Yinghui
    Ju, Zizhao
    Zhang, Xiaoqing
    Zheng, Lingling
    Li, Jun
    Sun, Yu
    Liu, Xingdang
    ANNALS OF NUCLEAR MEDICINE, 2020, 34 (09) : 675 - 681